Drug – bio-affecting and body treating compositions – Topical body preparation containing solid synthetic organic... – Skin burn or open wound treatment
Patent
1995-06-07
1997-06-24
Krass, Frederick
Drug, bio-affecting and body treating compositions
Topical body preparation containing solid synthetic organic...
Skin burn or open wound treatment
514 8, A61K 970, A61K 3800
Patent
active
056414838
ABSTRACT:
Topical gel and cream formulations containing human plasma fibronectin are used for the healing of cutaneous wounds. The formulations provide slow release and increased contact time of fibronectin to the wound site leading to effective absorption of an effective wound healing amount of fibronectin in the skin.
REFERENCES:
patent: 4455300 (1984-06-01), Wallace et al.
patent: 4740498 (1988-04-01), Hirao et al.
patent: 4837019 (1989-06-01), Georgalas et al.
patent: 4925924 (1990-05-01), Silver et al.
patent: 4929442 (1990-05-01), Powell
patent: 4973466 (1990-11-01), Reich
patent: 5045631 (1991-09-01), Kimizuka et al.
patent: 5053388 (1991-10-01), Gibson et al.
patent: 5102988 (1992-04-01), Kimizuka et al.
patent: 5124155 (1992-06-01), Reich
patent: 5427778 (1995-06-01), Finkenaur et al.
Hynes, R.O., Methods for identification of fibronectin (chap. 2, p. 12), IN: Fibronectins New York: Springer-Verlag, 1990.
Hynes, R.O., Methods for identification of fibronectin (chap. 2, pp. 7-23) and Wound healing, inflammation, and fibrosis (chap. 14, pp. 349-364), IN: Fibronectins New York: Springer-Verlag, 1990.
Brotchie, H., Wakefield, D. Fibronentin: Structure, function and significance in wound healing. Australas J. Dermatol 1990; 31:47-56.
Nishida, T. et al., Rapid Preparation of Purified Autologous Fibronectin Eyedrops, Jpn. J. Ophthalmol (1982) 26:416-24.
Phan, T. M. et al., Topical Fibronectin in the Treatment of Persistent Corneal Epithelial Defects and Trophic Ulcers, Am. J. Ophthalmol (1987) 104:494-501.
Wysocki, A. et al., Topical Fibronectin Therapy for Treatment of a Patient With Chronic Stasis Ulcers, Arch Dermatol (1988) 124:175-77.
Edwards, C.A. et al., Tri (n-butyl) Phosphate/Detergent Treated of Licensed Therapeutic and Experimental Blood Derivatives, Vox Sang (1987) 52:53-59.
Horowitz, B. et al., Solvent/Detergent-Treated Plasma: A Virus-Inactivated Substitute for Fresh Frozen Plasma, Blood (1992) 79:826-31.
Grinnell, F. et al., Degradation of Fibronectin and Vitronentin in Chronic Wound Fluid: Analysis by Cell Blotting, Immunoblotting and Cell Adhesion Assays, J. Invest Dermatol (1992) 98:410-416.
Chen, W.Y.J. et al., Characterization of Biologic Properties of Wound Fluid Collected During Early Stages of Wound Healing, J. Invest Dermatol (1992) 99:559-64.
Berman, M. et al., Ulceration is Correlated With Degradation of Fibrin and Fibronectin at the Corneal Surface, Invest Ohpthalmol Vis Sci (1983) 24:1358-66.
Horowitz, N. et al., Preparation of Fibronectin for Therapeutic Administration, IN: D. F. Mosher (ed.), Fibronectin, pp. 441-55, San Diego, Academic Press (1989).
Franz, T.J., Percutaneous Absortion. On the Relevance of In Vitro Data, J Invest Dermatol (1975) 64:190-95.
Bronaugh, R.L. et al., Methods for In Vitro Percutaneous Absorption Studies I: Comparison with In Vivo Results, Toxicol Appl Pharmacol (1982) 62:474-80.
Bronaugh, R.L. et al., Methods for In Vitro Percutaneous Absorption Studies IV: The Flow-Through Diffusion Cell, J Pharm Sci (1985) 74:64-67.
Saba, T.M. et al., "Prevention of Liver Reticuloendothelial Systemic Host Failure After Surgery by Intraveous Opsonic Glycoprotein Therapy," Annals of Surgery, 188:142-52 (1978).
Scovill, W.A. et al., "Opsonic .alpha..sub.2 Surface Binding Glycoprotein Therapy During Sepsis," Annals of Surgery, 188:521-29 (1978).
Yamada, K.M. et al., "Fibronectins--Adhesive Glycoproteins of Cell Surface and Blood," Nature, 275:179-84 (1978).
Denaturing (SDS) Discontinuous Gel Electrophoresis: Laemmli Gel Method, pp. 10.2.4-10.2.9, Current Protocols in Molecular Biology (1994).
Pharmaceuticals and Specialties Compendium, p. 1215, Canadian Pharmaceutical Assn. (1995).
LandOfFree
Wound healing formulations containing human plasma fibronectin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Wound healing formulations containing human plasma fibronectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wound healing formulations containing human plasma fibronectin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-147674